Cargando…
Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes
Medicine continues to struggle in its approaches to numerous common subjective pain syndromes that lack objective signs and remain treatment resistant. Foremost among these are migraine, fibromyalgia, and irritable bowel syndrome, disorders that may overlap in their affected populations and whose su...
Autor principal: | Russo, Ethan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576607/ https://www.ncbi.nlm.nih.gov/pubmed/28861491 http://dx.doi.org/10.1089/can.2016.0009 |
Ejemplares similares
-
Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment
por: Brugnatelli, Viola, et al.
Publicado: (2020) -
The Frequency of Primary Sjogren’s Syndrome and Fibromyalgia in Irritable Bowel Syndrome
por: Erbasan, Funda, et al.
Publicado: (2017) -
Irritable Bowel Syndrome and Migraine: Bystanders or Partners?
por: Chang, Full-Young, et al.
Publicado: (2013) -
The role of mind body interventions in the treatment of irritable bowel syndrome and fibromyalgia
por: Islam, Zarmina, et al.
Publicado: (2022) -
Migraine and fibromyalgia
por: de Tommaso, Marina
Publicado: (2015)